Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -9,6 +9,9 @@
9	9	* In October 2020, the company raised fresh equity from The Carlyle Group for a 20% stake in Piramal Pharma.
10	10
11	11
	12	+[[image:PEL0.png||height="273" width="614"]]
	13	+
	14	+
12	12	= Company Overview =
13	13
14	14	Piramal Group is a global business conglomerate with diverse interests in Pharma, Financial Services and Real Estate. The Group has offices in over 30 countries and a global brand presence in more than 100 markets.{{footnote}}https://www.piramal.com/about-us/who-we-are/{{/footnote}}
...	...	@@ -16,6 +16,9 @@
16	16	Piramal Enterprises Limited (NSE: PEL) is one of India’s leading diversified companies, with a presence in Financial Services and Pharmaceuticals. PEL’s consolidated revenues were ~~US$1.7 Billion in FY2021, with around ~~37% of revenues generated from outside India. Driven by both organic as well as inorganic strategy, PEL has steered dynamic business growth over the three decades of its existence.
17	17
18	18
	22	+[[image:PEL2.jpg]]
	23	+
	24	+
19	19	== Financial Services ==
20	20
21	21	The Company offers a wide range of financial products and solutions, with presence across both retail and wholesale financing. As of March 31, 2021, the Financial Services business had loan book of Rs 44,668 Crore.
...	...	@@ -36,6 +36,67 @@
36	36	In October 2020, the company raised fresh equity from The Carlyle Group for a 20% stake in Piramal Pharma.
37	37
38	38
	45	+== Plant Locations ==
	46	+
	47	+**Plant Locations of the Company (PEL) and its Subsidiaries**
	48	+
	49	+
	50	+=== India ===
	51	+
	52	+**PEL**
	53	+
	54	+* Raigad,Maharashtra
	55	+
	56	+
	57	+**Piramal Pharma Limited**
	58	+
	59	+* Dhar,Madhya Pradesh
	60	+* Zaheerabad,Telangana
	61	+* Chennai,Tamil Nadu
	62	+* Ahmedabad,Gujarat
	63	+
	64	+
	65	+**Convergence Chemicals Private Limited**
	66	+
	67	+* Dahej, Tal Vagra,Gujarat
	68	+
	69	+===
	70	+ Overseas: ===
	71	+
	72	+
	73	+**Piramal Healthcare UK Limited**
	74	+
	75	+* Northumberland,UK
	76	+* Scotland,UK
	77	+
	78	+
	79	+**Piramal Healthcare (Canada) Limited**
	80	+
	81	+* Aurora, Ontario,Canada
	82	+
	83	+**iramal Critical Care Inc.**
	84	+
	85	+* Brodhead Road,USA
	86	+
	87	+
	88	+**Piramal Pharma Solutions Inc.**
	89	+
	90	+* Kentucky,USA
	91	+
	92	+
	93	+**Ash Stevens LLC**
	94	+
	95	+* Krause Street, Riverview,USA
	96	+
	97	+
	98	+**PEL Healthcare LLC**
	99	+
	100	+* Sellersville,USA
	101	+
	102	+
	103	+[[image:PEL1.png]]
	104	+
	105	+
39	39	= Business Overview =
40	40
41	41
...	...	@@ -87,7 +87,7 @@
87	87
88	88	Going forward, the progress of the vaccination drive in the country and the government’s stance on restrictions will be the key influencers of the sector’s performance in the near term. Moreover, the pandemic is likely to further accelerate the pace of the on-going consolidation in the sector.
89	89
90		-In line with the Company’s stated strategy, the overall loan book reduced from `50,963 Crore as of March 2020 to `44,668 Crore as of March 2021. FY2021 revenues of Financial Services were impacted, primarily due to a reduction in the wholesale loan book. Revenues declined 8% yoy from `7,649 Crore in FY2020 to `7,033 Crore in FY2021. Further, the business reported a post-tax return on equity (ROE) of 10% for FY2021 as compared to 12.4% (on a normalised basis) for FY2020, amidst a fall in revenues and an increase in the equity base during the year.
	157	+In line with the Company’s stated strategy, the overall loan book reduced from Rs 50,963 Crore as of March 2020 to Rs44,668 Crore as of March 2021. FY2021 revenues of Financial Services were impacted, primarily due to a reduction in the wholesale loan book. Revenues declined 8% yoy from `7,649 Crore in FY2020 to Rs 7,033 Crore in FY2021. Further, the business reported a post-tax return on equity (ROE) of 10% for FY2021 as compared to 12.4% (on a normalised basis) for FY2020, amidst a fall in revenues and an increase in the equity base during the year.
91	91
92	92
93	93	== PHARMA ==